{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:23:35Z","timestamp":1791069815799,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.bone.2009.07.011","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T07:09:12Z","timestamp":1248332952000},"page":"843-852","source":"Crossref","is-referenced-by-count":192,"title":["Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?"],"prefix":"10.1016","volume":"45","author":[{"given":"Philippe","family":"Lesclous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semaan","family":"Abi Najm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Carrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Baroukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Saffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.07.011_bib1","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2009.07.011_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.07.011_bib3","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the american society for bone and mineral research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.07.011_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphophonates","volume":"353","author":"Durie","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.07.011_bib5","first-page":"8580","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphophonates: incidence and risk factors","volume":"34","author":"Bamias","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2009.07.011_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.07.011_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib8","first-page":"502","article-title":"Alveolar bone remodelling in the rat: normal status and effects of PTX and PTH on remodelling sequence and the osteoclastic pool","volume":"22 Suppl","author":"Baron","year":"1977","journal-title":"Calcif. Tissue Res."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2009.07.011_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","article-title":"The pharmacology of bisphosphonates and new insights into their mechanisms of action","volume":"14","author":"Russel","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.07.011_bib10","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.07.011_bib11","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.07.011_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates: histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bone.2009.07.011_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","article-title":"Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis","volume":"144","author":"Scheper","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bone.2009.07.011_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.07.011_bib16","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bone.2009.07.011_bib17","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.07.011_bib18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","article-title":"Mandible matrix necrosis in beagle dogs after 3\u00a0years of daily oral bisphosphonate treatment","volume":"66","author":"Allen","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.07.011_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"Position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.07.011_bib20","article-title":"Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis","author":"Tubiana-Hulin","year":"2008","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.bone.2009.07.011_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00221-006-0719-9","article-title":"Forces applied by anterior and posterior teeth and roles of periodontal afferents during hold-and-split tasks in human subject","volume":"178","author":"Johnsen","year":"2007","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bone.2009.07.011_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00298728","article-title":"Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induced a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes and osteoclasts in vivo","volume":"52","author":"Endo","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.07.011_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bone.2006.02.060","article-title":"Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts\/osteocytes with novel analogs","volume":"39","author":"Plotkin","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bone.2006.12.052","article-title":"Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading","volume":"40","author":"Follet","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/8756-3282(85)90053-5","article-title":"Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse","volume":"6","author":"Marie","year":"1985","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1309\/DGEA9BE2VE5VCFYH","article-title":"Tartrate-resistant acid phosphatase as an immunohistochemical marker for inflammatory macrophages","volume":"127","author":"Janckila","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bone.2009.07.011_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2613.2000.00164.x","article-title":"Osteoclasts and giant cells: macrophage\u2013macrophage fusion mechanism","volume":"81","author":"Vignery","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bone.2009.07.011_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(99)00094-0","article-title":"Calcitonin receptor antibodies in the identification of osteoclasts","volume":"25","author":"Quinn","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Systematic review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2009.07.011_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1601-0825.2007.01402.x","article-title":"Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate","volume":"14","author":"Stefanik","year":"2008","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2009.07.011_bib32","first-page":"613","article-title":"Variations in structure within the trabecular bone of the mandible","volume":"85","author":"von Wowern","year":"1977","journal-title":"Scand. J. Dent. Res."},{"issue":"13","key":"10.1016\/j.bone.2009.07.011_bib33","first-page":"76","article-title":"Alveolar bone and the alveolar process: the socket is never stable","volume":"1997","author":"Saffar","year":"2000","journal-title":"Periodontol."},{"key":"10.1016\/j.bone.2009.07.011_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biochemical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","article-title":"Alterations in canine vertebral bone turnover, microdamage accumulation, and biochemical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate","volume":"39","author":"Allen","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.07.011_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1138\/20060248","article-title":"Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone?","volume":"4","author":"Allen","year":"2007","journal-title":"IBMS BoneKEY-Osteovision"},{"key":"10.1016\/j.bone.2009.07.011_bib37","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1359\/jbmr.070720","article-title":"Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment","volume":"22","author":"Allen","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.07.011_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1359\/jbmr.2000.15.1.60","article-title":"Loss of osteocyte integrity in association with microdamage and bone remodelling after fatigue in vivo","volume":"15","author":"Verbogt","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.07.011_bib39","first-page":"269","article-title":"Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities","volume":"18","author":"Santini","year":"2004","journal-title":"Bio Drugs"},{"key":"10.1016\/j.bone.2009.07.011_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","article-title":"The acute-phase response after bisphosphonate administration","volume":"41","author":"Adami","year":"1987","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.07.011_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.intimp.2006.09.009","article-title":"Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: Involvement of mevalonate pathway, TNF\u03b1, macrophages and T-cells","volume":"7","author":"Deng","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bone.2009.07.011_bib42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/rheumatology\/38.10.984","article-title":"Pro-inflammatory effects of the aminobisphosphonate ibandronate in vitro and in vivo","volume":"38","author":"Richards","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.bone.2009.07.011_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s002239900535","article-title":"The effect of alendronate on cytokine production, adhesion molecule expression and transendothelial migration of human peripheral blood mononuclear cells","volume":"63","author":"Pietschmann","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.07.011_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s000110300075","article-title":"Effects of ibandronate on inflammation in mouse antigen-induced arthritis","volume":"52","author":"Zysk","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bone.2009.07.011_bib45","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.07.011_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","article-title":"Sinus tracts: an early sign of bisphosphonate-associated osteonecrosis of the jaws?","volume":"67","author":"Mawardi","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.07.011_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.59.2.193","article-title":"Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation","volume":"59","author":"Reszka","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bone.2009.07.011_bib48","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bone.2009.07.011_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.critrevonc.2007.07.005","article-title":"Pathophysiology, risk factor and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates?","volume":"64","author":"Diel","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bone.2009.07.011_bib50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bone.2009.07.011_bib51","first-page":"32","article-title":"Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial","volume":"139","author":"Grbic","year":"2008","journal-title":"JADA"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209016822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209016822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T12:58:33Z","timestamp":1558443513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209016822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S8756328209016822"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.07.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}